-
Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018
- Maria Koliou1,2 , Diamanto Kasapi1 , Stella Mazeri3,4 , Panagiota Maikanti5 , Anna Demetriou6 , Chrystalla Skordi7 , Maria Agathocleous8 , Georgina Tzanakaki9 , Elisavet Constantinou10
-
View Affiliations Hide AffiliationsAffiliations: 1 Medical School, University of Cyprus, Nicosia, Cyprus 2 Unit for Surveillance and control of Communicable diseases, Medical and Public Health Services, Ministry of Health, Nicosia, Cyprus 3 The Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Edinburgh, United Kingdom 4 The Roslin Institute, Division of Genetics and Genomics, Easter Bush Veterinary Centre, Roslin, United Kingdom 5 Department of Microbiology, Nicosia General Hospital, Nicosia, Cyprus 6 Health Monitoring Unit, Ministry of Health, Nicosia, Cyprus 7 Larnaca General Hospital, Larnaca, Cyprus 8 Paediatric Department, Limassol General Hospital, Limassol, Cyprus 9 National Meningitis Reference Laboratory, Department of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece 10 Medical and Public Health Services, Ministry of Health, Nicosia, CyprusMaria G. Kolioukoliou-mazeri.maria ucy.ac.cy
-
View Citation Hide Citation
Citation style for this article: Koliou Maria, Kasapi Diamanto, Mazeri Stella, Maikanti Panagiota, Demetriou Anna, Skordi Chrystalla, Agathocleous Maria, Tzanakaki Georgina, Constantinou Elisavet. Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018. Euro Surveill. 2020;25(30):pii=1900534. https://doi.org/10.2807/1560-7917.ES.2020.25.30.1900534 Received: 17 Aug 2019; Accepted: 10 Jan 2020
Abstract
Despite progress in the management of invasive meningococcal disease (IMD) it causes significant mortality and sequelae.
This study aims to describe the epidemiology and clinical characteristics of IMD in Cyprus and discuss the current immunisation programmes.
This is a retrospective study of all cases of IMD notified to the Ministry of Health between 2004 and 2018. Demographic, epidemiological, clinical and microbiological data were collected when a new case was notified. Risk factors associated with mortality were investigated using univariable logistic regression.
54 cases of IMD were recorded, an overall incidence of 0.4 cases per 100,000 population. The incidence rate was highest among infants (7.2/100,000) and adolescents (1.4/100,000). Case fatality rate was 10.4%. Serogroup B accounted for 24 of 40 cases caused by known serogroup. Serogroups W and Y comprised nine cases and were responsible for most fatal cases. Serogroup C was the cause in only four cases. There was an increase in the odds of death with increasing age, while the presence of meningitis in the clinical picture was found to be associated with lower odds of death.
Despite the low incidence of IMD in Cyprus, it remains an important cause of morbidity and mortality. Serogroup B is the most frequent serogroup, while incidence of serogroups W and Y is rising. Monitoring new cases and yearly evaluation of the immunisation programmes by the National Immunization Technical Advisory Group (NITAG) is essential for successful control of the disease.
Article metrics loading...
Full text loading...
References
-
Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect. 1987;99(3):591-601. https://doi.org/10.1017/S0950268800066449 PMID: 3123263
-
Public Health England (PHE). Meningococcal: the green book, chapter 22. London: PHE; 2016. Available from: https://www.gov.uk/government/publications/meningococcal-the-green-book-chapter-22
-
Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(Suppl 2):B3-9. https://doi.org/10.1016/j.vaccine.2011.12.062 PMID: 22607896
-
Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27(Suppl 2):B51-63. https://doi.org/10.1016/j.vaccine.2009.04.063 PMID: 19477562
-
Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, et al. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Vaccine. 2017;35(16):2034-41. https://doi.org/10.1016/j.vaccine.2017.03.007 PMID: 28314560
-
European Centre for Disease Prevention and Control (ECDC). Invasive meningococcal disease. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-invasive-meningococcal-disease.pdf
-
Kirsch EA, Barton RP, Kitchen L, Giroir BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J. 1996;15(11):967-78, quiz 979. https://doi.org/10.1097/00006454-199611000-00009 PMID: 8933544
-
Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, et al. A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev. 2007;31(1):27-36. https://doi.org/10.1111/j.1574-6976.2006.00060.x PMID: 17168995
-
Darton T, Guiver M, Naylor S, Jack DL, Kaczmarski EB, Borrow R, et al. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009;48(5):587-94. https://doi.org/10.1086/596707 PMID: 19191644
-
Cohn AC, MacNeil JR, Harrison LH, Hatcher C, Theodore J, Schmidt M, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50(2):184-91. https://doi.org/10.1086/649209 PMID: 20001736
-
Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, et al. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin Infect Dis. 2015;60(8):e27-35. https://doi.org/10.1093/cid/civ028 PMID: 25605282
-
Campbell H, Andrews N, Borrow R, Trotter C, Miller E. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol. 2010;17(5):840-7. https://doi.org/10.1128/CVI.00529-09 PMID: 20219881
-
Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004;364(9431):365-7. https://doi.org/10.1016/S0140-6736(04)16725-1 PMID: 15276396
-
Maiden MC, Stuart JM, UK Meningococcal Carraige Group. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet. 2002;359(9320):1829-31. https://doi.org/10.1016/S0140-6736(02)08679-8 PMID: 12044380
-
Bröker M, Bukovski S, Culic D, Jacobsson S, Koliou M, Kuusi M, et al. Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012. Hum Vaccin Immunother. 2014;10(6):1725-8. https://doi.org/10.4161/hv.28206 PMID: 24608912
-
Krone M, Gray S, Abad R, Skoczyńska A, Stefanelli P, van der Ende A, et al. Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017. Euro Surveill. 2019;24(14). https://doi.org/10.2807/1560-7917.ES.2019.24.14.1800245 PMID: 30968827
-
Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR-2):1-28. PMID: 23515099
-
European Centre for Disease Prevention and Control (ECDC). Surveillance of invasive bacterial diseases in Europe, 2012. Stockholm: ECDC; 2015. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Surveillance%20of%20IBD%20in%20Europe%202012.pdf
-
Ladhani SN, Flood JS, Ramsay ME, Campbell H, Gray SJ, Kaczmarski EB, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine. 2012;30(24):3710-6. https://doi.org/10.1016/j.vaccine.2012.03.011 PMID: 22429756
-
Parikh SR, Andrews NJ, Beebeejaun K, Campbell H, Ribeiro S, Ward C, et al. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016;388(10061):2775-82. https://doi.org/10.1016/S0140-6736(16)31921-3 PMID: 28100432
-
Unit for surveillance and control of communicable diseases, Medical and public health services. National Vaccination Coverage survey in toddlers 17-24 months old, 2015. Nicosia: Cyprus Ministry of Health; 2015.
-
Unit for Surveillance and Control of Communicable Diseases, Medical and Public Health Services. National Vaccination Coverage survey in toddlers 17-24 months old, 2009. Nicosia: Cyprus Ministry of Health; 2009.
-
European Centre for Disease Prevention and Control (ECDC). Invasive meningococcal disease, In: ECDC Annual epidemiological report for 2016, Stockholm: ECDC; 2018. Available from: https://ecdc.europa.eu/en/publications-data/invasive-meningococcal-disease-annual-epidemiological-report-2016
-
Statistical service of Cyprus (CYSTAT) – Ministry of Finance. Demographic Report 2017. Nicosia: CYSTAT; 2018 Available from: https://www.mof.gov.cy/mof/cystat/statistics.nsf/All/77A0741D88AEB4B7C225834E003F69F2/$file/Demographic_Report-2017-EN-301118.pdf?OpenElement
-
European Commission. Commission Implementing Decision of 8 August 2012 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. 2012. Available from: https://publications.europa.eu/en/publication-detail/-/publication/10ed460f-0711-11e2-8e28-01aa75ed71a1/language-en
-
Piscopo T, Mallia-Azzopordi C, Grech V, Muscat M, Attard-Montalto S, Mallia C. Epidemiology and prognostic factors in meningococcal disease in a small island population: Malta 1994-1998. Eur J Epidemiol. 2000;16(11):1051-6. https://doi.org/10.1023/A:1010865315425 PMID: 11421475
-
Ó Maoldomhnaigh C, Drew RJ, Gavin P, Cafferkey M, Butler KM. Invasive meningococcal disease in children in Ireland, 2001-2011. Arch Dis Child. 2016;101(12):1125-9. https://doi.org/10.1136/archdischild-2015-310215 PMID: 27566800
-
World Health Organization (WHO). Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenza. In: WHO Manual. 2nd ed. Chapter 7. WHO/ CDS/CSR/EDC/99.7. Geneva: WHO; 2011. Available from: https://www.cdc.gov/meningitis/lab-manual/full-manual.pdf
-
Tzanakaki G, Tsopanomichalou M, Kesanopoulos K, Matzourani R, Sioumala M, Tabaki A, et al. Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae. Clin Microbiol Infect. 2005;11(5):386-90. https://doi.org/10.1111/j.1469-0691.2005.01109.x PMID: 15819865
-
Drakopoulou Z, Kesanopoulos K, Sioumala M, Tambaki A, Kremastinou J, Tzanakaki G. Simultaneous single-tube PCR-based assay for the direct identification of the five most common meningococcal serogroups from clinical samples. FEMS Immunol Med Microbiol. 2008;53(2):178-82. https://doi.org/10.1111/j.1574-695X.2008.00406.x PMID: 18623625
-
Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA. 1998;95(6):3140-5. https://doi.org/10.1073/pnas.95.6.3140 PMID: 9501229
-
Russell JE, Jolley KA, Feavers IM, Maiden MC, Suker J. PorA variable regions of Neisseria meningitidis. Emerg Infect Dis. 2004;10(4):674-8. https://doi.org/10.3201/eid1004.030247 PMID: 15200858
-
Thompson EAL, Feavers IM, Maiden MCJ. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology. 2003;149(Pt 7):1849-58. https://doi.org/10.1099/mic.0.26131-0 PMID: 12855736
-
Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, et al. Multicenter evaluation of biofire filmarray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54(9):2251-61. https://doi.org/10.1128/JCM.00730-16 PMID: 27335149
-
R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. Available from: https://www.R-project.org/
-
Wickham H. ggplot2: Elegant graphics for data analysis. New York: Springer; 2016.
-
Heinze G, Ploner M, Dunkler D, Southworth H. logistf: Firth's bias-reduced logistic regression. R package version 1.23. 2018. Available from: https://CRAN.R-project.org/package=logistf
-
Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409-19. https://doi.org/10.1002/sim.1047 PMID: 12210625
-
National Immunisation Advisory Committee . Immunisation guidelines. Chapter 13 – Meningococcal Infection. Dublin: Health Service Executive (HSE); 2019. Available from: https://www.hse.ie/eng/health/immunisation/hcpinfo/guidelines/chapter13.pdf
-
MacNeil JR, Bennett N, Farley MM, Harrison LH, Lynfield R, Nichols M, et al. Epidemiology of infant meningococcal disease in the United States, 2006-2012. Pediatrics. 2015;135(2):e305-11. https://doi.org/10.1542/peds.2014-2035 PMID: 25583921
-
Dunlop KA, Coyle P, Mitchell S, Fairley D, O’Neill H, Jackson P, et al. Molecular testing of respiratory swabs aids early recognition of meningococcal disease in children. Diagn Microbiol Infect Dis. 2011;70(4):427-34. https://doi.org/10.1016/j.diagmicrobio.2011.03.018 PMID: 21658876
-
Judelsohn R, Marshall GS. The burden of infant meningococcal disease in the United States. J Pediatric Infect Dis Soc. 2012;1(1):64-73. https://doi.org/10.1093/jpids/pir003 PMID: 23687573
-
European Centre for Disease Prevention and Control (ECDC). Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU/EEA. Stockholm: ECDC; 2017. Available from: https://ecdc.europa.eu/en/publications-data/expert-opinion-introduction-meningococcal-b-4cmenb-vaccine-eueea
-
American College Health Association (ACHA). Immunization recommendations for college students. Silver Spring: ACHA; 2018. Available from: https://www.acha.org/documents/resources/guidelines/ACHA_Immunization_Recommendations_Oct2018.pdf
-
Public Health England (PHE). MenACWY: Information on vaccination for first time university entrants. London: PHE; 2015. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/443670/MenACWY_vaccination_university_letter_FINAL08_07_15.pdf
-
Maclean IH, Bevan CE. Observations on an epidemic of cerebrospinal meningitis in Cyprus and the record of a prophylactic experiment: (Section of Epidemiology and State Medicine). Proc R Soc Med. 1939;32(12):1551-72. https://doi.org/10.1177/003591573903201201 PMID: 19992142
-
Jacobs JH, Viboud C, Tchetgen ET, Schwartz J, Steiner C, Simonsen L, et al. The association of meningococcal disease with influenza in the United States, 1989-2009. PLoS One. 2014;9(9):e107486. https://doi.org/10.1371/journal.pone.0107486 PMID: 25265409
-
Rameix-Welti MA, Zarantonelli ML, Giorgini D, Ruckly C, Marasescu M, van der Werf S, et al. Influenza A virus neuraminidase enhances meningococcal adhesion to epithelial cells through interaction with sialic acid-containing meningococcal capsules. Infect Immun. 2009;77(9):3588-95. https://doi.org/10.1128/IAI.00155-09 PMID: 19528219
Data & Media loading...